Harlingen Medical Center & Texas State Technical College Team Up to Raise Awareness for Celiac Disease

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

About the Event

Harlingen Medical Center (HMC) & Texas State Technical College (TSTC) are teaming up to promote health and wellness and raise awareness of Celiac Disease – with the first HMC & TSTC Celiac Disease Awareness 5k Run/1m Walk.  The goal with the run-walk is to bring education to the residents of South Texas regarding the health-related risks linked to celiac disease, which is a genetic autoimmune disorder where the ingestion of gluten leads to possible damage in the small intestine.

The Run/Walk

- Advertisement -

The Run-Walk is OPEN TO THE COMMUNITY!  It will feature complimentary basic medical screenings, health and wellness education, a Zumba-warm-up session prior to the run/walk, an Education Expo with demonstrations on healthy meal preparation, gluten-free food options, education on celiac disease, Doc Talk Lectures featuring expert presentations on healthy-living, fun activities for young children, and much more! 

Registration is NOW OPEN

To register as a participant of the Run-Walk, you may do so by downloading the attached Participant Registration Form and returning to the Marketing Office at Harlingen Medical Center (located inside the Administration Offices), with payment; or, you may register on-line at:https://www.eventbrite.com/e/harlingen-medical-center-tstc-1st-annual-celiac-disease-awareness-run-walk-tickets-33446274708.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Cybersecurity Alert as Hackers Exploit Computer and Smartphone Vulnerabilities

Federal cybersecurity authorities are urging computer and smartphone users to keep their devices updated following reports of actively exploited security vulnerabilities affecting Apple products and Google’s Chrome browse

American Cancer Society Updates Prostate Cancer Screening Guideline

The American Cancer Society (ACS) released an updated guideline for prostate cancer screening to help find cancer before it spreads and reduce the risk of dying from the disease.

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

Embolism Treatment Developed at University of Michigan receives FDA clearance 

Patients with persistent blood clots require frequent medical interventions just to survive. Yet despite this critical need, there have been few advancements in how these patients are treated. 
- Advertisement -